WALNUT CAP (00905) issues profit warning, expecting a net loss of not less than HK$170 million for the year 2025.

19:32 24/03/2026

Walnut Capital (00905) issued an announcement, expecting to achieve a net loss of approximately no less than HK$170 million for the year ending December 31, 2025, while it recorded a net profit of approximately HK$400,000 for the year 2024. The shift from profit to loss is mainly due to: (i) recognition of impairment losses on cryptocurrency of approximately HK$142.9 million and losses on the sale of cryptocurrency of approximately HK$7.4 million; (ii) the net income generated by fair value changes in financial assets accounted for at fair value through profit or loss in the 2024 fiscal year was approximately HK$17.4 million, which turned into a loss of no less than HK$20 million in the fiscal year 2025 from the fair value changes in financial assets accounted for at fair value through profit or loss.

WALNUT CAP (00905) announced that the Group is expected to incur a net loss of not less than HK$170 million for the year ending December 31, 2025, while it achieved a net profit of approximately HK$400,000 for the year 2024. The change from profit to loss is mainly due to: (i) impairment losses of approximately HK$142.9 million for cryptocurrencies and losses of approximately HK$7.4 million from the sale of cryptocurrencies; (ii) net income of approximately HK$17.4 million in fair value change of financial assets through profit and loss account disclosed in 2024 changed to a net loss of not less than HK$2 million for the year ending in 2025 through profit and loss account disclosure of fair value changes for financial assets.

LIVZON PHARMA (01513): Ran Yongmei appointed as a member of the Board's Strategic Committee.

Daqian Ecology & Environment Group's major shareholder, Source Technology, plans to reduce its stake by no more than 3%.

SINOMAX GROUP (01418) announces annual performance, with a net profit of HK$60.3 million attributable to shareholders, a decrease of 56.33% compared to the previous year.

LIVZON PHARMA (01513): Ran Yongmei appointed as a member of the Board's Strategic Committee.

Daqian Ecology & Environment Group's major shareholder, Source Technology, plans to reduce its stake by no more than 3%.

SINOMAX GROUP (01418) announces annual performance, with a net profit of HK$60.3 million attributable to shareholders, a decrease of 56.33% compared to the previous year.